126 related articles for article (PubMed ID: 38078671)
21. MicroRNA-133b Ameliorates Allergic Inflammation and Symptom in Murine Model of Allergic Rhinitis by Targeting Nlrp3.
Xiao L; Jiang L; Hu Q; Li Y
Cell Physiol Biochem; 2017; 42(3):901-912. PubMed ID: 28662502
[TBL] [Abstract][Full Text] [Related]
22. Alpha-linolenic acid improves nasal mucosa epithelial barrier function in allergic rhinitis by arresting CD4
Ding Y; Wang Y; Zhang Y; Dang B; Hu S; Zhao C; Huang Y; Zheng G; Ma T; Zhang T
Phytomedicine; 2023 Jul; 116():154825. PubMed ID: 37178572
[TBL] [Abstract][Full Text] [Related]
23. Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways.
Akasaki S; Matsushita K; Kato Y; Fukuoka A; Iwasaki N; Nakahira M; Fujieda S; Yasuda K; Yoshimoto T
Int Immunol; 2016 Feb; 28(2):65-76. PubMed ID: 26428949
[TBL] [Abstract][Full Text] [Related]
24. Ameliorative potential of galangin in murine model of ovalbumin-induced allergic rhinitis: a role of PI3K-PKB pathway.
Chen J; Zhou Y
Am J Vet Res; 2024 Jun; 85(6):. PubMed ID: 38697189
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-155 plays critical effects on Th2 factors expression and allergic inflammatory response in type-2 innate lymphoid cells in allergic rhinitis.
Zhu YQ; Liao B; Liu YH; Wang Z; Zhu XH; Chen XB; Wang MQ
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4097-4109. PubMed ID: 31173279
[TBL] [Abstract][Full Text] [Related]
26. [Construction of recombinant house dust mite group 1 allergen vaccine and study on immune response induced by nasal immunization].
Shi WD; Cao W; Liu Y; Xu Y; Tao ZZ; Dai Q
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jan; 48(1):26-31. PubMed ID: 23656812
[TBL] [Abstract][Full Text] [Related]
27. Changes in IL-4 and IL-13 expression in allergic-rhinitis treated with hydrogen-rich saline in guinea-pig model.
Zhao C; Yu S; Li J; Xu W; Ge R
Allergol Immunopathol (Madr); 2017; 45(4):350-355. PubMed ID: 28215576
[TBL] [Abstract][Full Text] [Related]
28. Intranasal immunization with phosphorylcholine suppresses allergic rhinitis in mice.
Miyashita K; Ohori J; Nagano H; Fukuyama S; Kurono Y
Laryngoscope; 2018 Jul; 128(7):E234-E240. PubMed ID: 29193138
[TBL] [Abstract][Full Text] [Related]
29. Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release.
Bui TT; Piao CH; Song CH; Chai OH
Int Immunopharmacol; 2017 Nov; 52():77-84. PubMed ID: 28886581
[TBL] [Abstract][Full Text] [Related]
30. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and Th2-skew immune response in a rat model of AR.
Sun N; Niu Y; Zhang R; Huang Y; Wang J; Qiu W; Zhang X; Han Z; Bao J; Zhu H; Duan Y; Kan H
Biomed Pharmacother; 2021 May; 137():111261. PubMed ID: 33482509
[TBL] [Abstract][Full Text] [Related]
31. Water-soluble chitosan inhibits nerve growth factor and attenuates allergic inflammation in mite allergen-induced allergic rhinitis.
Chen PC; Hsieh MH; Kuo WS; Kao HF; Hsu CL; Wang JY
J Allergy Clin Immunol; 2017 Oct; 140(4):1146-1149.e8. PubMed ID: 28412394
[No Abstract] [Full Text] [Related]
32. Therapeutic effects of SKF-96365 on murine allergic rhinitis induced by OVA.
Ba G; Tang R; Sun X; Li Z; Lin H; Zhang W
Int J Immunopathol Pharmacol; 2021; 35():20587384211015054. PubMed ID: 33983057
[TBL] [Abstract][Full Text] [Related]
33. The role of hypoxia-inducible factor 1α in allergic rhinitis.
Mo JH; Kim JH; Lim DJ; Kim EH
Am J Rhinol Allergy; 2014; 28(2):e100-6. PubMed ID: 24717944
[TBL] [Abstract][Full Text] [Related]
34. Intranasal Administration of IL-27 Ameliorates Nasal Allergic Responses and Symptoms.
Suzuki M; Yokota M; Ozaki S; Matsumoto T
Int Arch Allergy Immunol; 2019; 178(2):101-105. PubMed ID: 30428479
[TBL] [Abstract][Full Text] [Related]
35. Honeysuckle extract relieves ovalbumin-induced allergic rhinitis by inhibiting AR-induced inflammation and autoimmunity.
Lin B; Cai B; Wang H
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31308153
[TBL] [Abstract][Full Text] [Related]
36. Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis.
Suzuki M; Yokota M; Nakamura Y; Ozaki S; Murakami S
Allergol Int; 2017 Apr; 66(2):351-356. PubMed ID: 27707583
[TBL] [Abstract][Full Text] [Related]
37. Petroleum extract of
Wu Y; Zhao X; Cui J; Guo Y; Zheng X; Zhang Y; Niu M; Li Z; Wen S; Gao W
Int J Med Sci; 2021; 18(2):555-563. PubMed ID: 33390825
[No Abstract] [Full Text] [Related]
38. Protein arginine methyltransferase 1 contributes to the development of allergic rhinitis by promoting the production of epithelial-derived cytokines.
Park JY; Choi JH; Lee SN; Cho HJ; Ahn JS; Kim YB; Park DY; Park SC; Kim SI; Kang MJ; Jang AR; Ahn JH; Lee TS; Kim DY; Shin SJ; Yoon JH; Park JH
J Allergy Clin Immunol; 2021 May; 147(5):1720-1731. PubMed ID: 33476674
[TBL] [Abstract][Full Text] [Related]
39. Silencing of forkhead box C1 reduces nasal epithelial barrier damage in mice with allergic rhinitis via epigenetically upregulating secreted frizzled-related protein 5.
Shi Z; Zhao T; Li D; Wang C; Luo Y; Zheng Y
Mol Immunol; 2024 Apr; 168():51-63. PubMed ID: 38422887
[TBL] [Abstract][Full Text] [Related]
40. RGFP966, a selective HDAC3 inhibitor, ameliorates allergic and inflammatory responses in an OVA-induced allergic rhinitis mouse model.
Zhang W; Sun X; Ba G; Tang R; Lin H
Int Immunopharmacol; 2021 Apr; 93():107400. PubMed ID: 33529911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]